All material subject to strictly enforced copyright laws. © 2022 Managing IP is part of the Euromoney Institutional Investor PLC group.

Podcast: Pharma insiders clash over COVID IP waiver

covid-waiver-min.jpeg

Guests from IFPMA, Knowledge Ecology International and Gowling WLG debate the necessity of waiving IP rights to COVID-19 vaccines

Earlier this month, US President Joe Biden shocked the pharmaceutical industry with his declared support for an intellectual property waiver for COVID-19 vaccines.

In this special podcast, reporter Charlotte Kilpatrick moderates a debate between Komal Kalha, lead for IP and trade policy at the International Federation of Pharmaceutical Manufacturers & Associations; James Love, director of Knowledge Ecology International; and Gordon Harris, partner at Gowling WLG.

In this heated debate, guests discuss the flexibilities of the TRIPS Agreement, know-how gaps, and whether the waiver – if implemented – could undermine incentives for future pharmaceutical research.

To listen to the 30-minute debate, click the link below.



 


more from across site and ros bottom lb

More from across our site

IP counsel say rude judges can dent their confidence but that the effect on clients should not be underestimated
Sources say the Supreme Court’s decision to take on Sky v SkyKick puts uncertainty back into the mix, just when IP owners thought they knew what was what
Charles Feng, partner at East & Concord in Beijing, explains why filing for a trademark early is still a brand’s best bet
Counsel at IBM, Novartis, BMS and four other companies delve into whether the new Section 101 bill addresses their concerns
Clearance searches are especially important when counsel can’t rely on the USPTO’s opinion before key deadlines, say sources
VLSI case halted in Delaware; Netflix sues Bridgerton rip-off; Ex-GSK scientist escapes damages; US Copyright Office debuts new software; Abbvie scores Humira patent thicket win; Russia tables bill on illegal blocking of copyrighted content
An England and Wales High Court judgment over a disclosure error shows why law firms must never play a distant role when advising clients
Italy is in pole position to replace London as a central division host but must weather a political storm first
The senator’s proposed Section 101 legislation would cut down on exceptions to patent eligibility in the US
Ken Korea, founder of Colev Law and former head of US IP at Samsung, sets out the problems with anti-suit injunctions and the problem of getting rid of them
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree